Abstract: Alzheimer disease (AD) is the most prevalent form of dementia. As the world population ages, the number of people suffering from dementia is increasing dramatically and yet we still ignore the pathophysiology of AD and lack effective therapeutic tools to deal with it. These two deficiencies, together with the search for early diagnostic tools, constitute the most obvious challenges in current biomedical research on AD. In the meantime, healthcare efforts are being addressed at improving the quality of life of AD patients, their family and their caregivers. In this context, Translational Medicine, an interdisciplinary branch within the biomedical field, is called upon to play a key role in transferring the knowledge acquired i...
Alzheimer disease (AD) is the most frequent cause of dementia in people 60 y old or older. This whit...
Background: Cognitive rehabilitation (CR) is an individualised, goal-based intervention for people...
Premis Pharmanews-Fedefarma 2019A few months ago, a promising study about Alzheimer Disease (AD), a ...
Alzheimer’s Disease Alzheimer’s Disease is a debilitating, chronic disease in which the brain is det...
The most common form of dementia in the elderly population is Alzheimer’s disease (AD). World Health...
Alzheimer’s disease (AD) is a generalized and progressive loss of (higher) mental function, affectin...
Epidemiological projections of the prevalence of Alzheimer's disease (AD) and related dementias, the...
Alzheimer's disease (AD) is the most common cause of dementia. The disease is typically found in peo...
Dementia, of which the most frequent form is Alzheimer's disease, is a chronic and terminal conditio...
Although significant accomplishments have been made in research to understand, diagnose and treat Al...
Alzheimer's disease (AD) is a neurological illness with a progressive course that is the most common...
Alzheimer’s disease is one of the most common neurodegenerative diseases in the western population. ...
Alzheimer's disease (AD) is defined as a multifactorial neurodegenerative pathology whose causes res...
Objectives: The aim of present study was to investigate the effect of cognitive rehabilitation, a ne...
Alzheimer disease (AD) is the most frequent cause of dementia in people 60 y old or older. This whit...
Alzheimer disease (AD) is the most frequent cause of dementia in people 60 y old or older. This whit...
Background: Cognitive rehabilitation (CR) is an individualised, goal-based intervention for people...
Premis Pharmanews-Fedefarma 2019A few months ago, a promising study about Alzheimer Disease (AD), a ...
Alzheimer’s Disease Alzheimer’s Disease is a debilitating, chronic disease in which the brain is det...
The most common form of dementia in the elderly population is Alzheimer’s disease (AD). World Health...
Alzheimer’s disease (AD) is a generalized and progressive loss of (higher) mental function, affectin...
Epidemiological projections of the prevalence of Alzheimer's disease (AD) and related dementias, the...
Alzheimer's disease (AD) is the most common cause of dementia. The disease is typically found in peo...
Dementia, of which the most frequent form is Alzheimer's disease, is a chronic and terminal conditio...
Although significant accomplishments have been made in research to understand, diagnose and treat Al...
Alzheimer's disease (AD) is a neurological illness with a progressive course that is the most common...
Alzheimer’s disease is one of the most common neurodegenerative diseases in the western population. ...
Alzheimer's disease (AD) is defined as a multifactorial neurodegenerative pathology whose causes res...
Objectives: The aim of present study was to investigate the effect of cognitive rehabilitation, a ne...
Alzheimer disease (AD) is the most frequent cause of dementia in people 60 y old or older. This whit...
Alzheimer disease (AD) is the most frequent cause of dementia in people 60 y old or older. This whit...
Background: Cognitive rehabilitation (CR) is an individualised, goal-based intervention for people...
Premis Pharmanews-Fedefarma 2019A few months ago, a promising study about Alzheimer Disease (AD), a ...